Cipla Limited (NSE:CIPLA)
India
· Delayed Price · Currency is INR | Market Cap | 1.21T |
| Revenue (ttm) | 274.80B |
| Net Income (ttm) | 53.93B |
| Shares Out | 807.75M |
| EPS (ttm) | 66.73 |
| PE Ratio | 22.47 |
| Forward PE | 25.12 |
| Dividend | 13.00 (0.87%) |
| Ex-Dividend Date | Jun 27, 2025 |
| Volume | 753,073 |
| Average Volume | 1,061,806 |
| Open | 1,506.90 |
| Previous Close | 1,499.40 |
| Day's Range | 1,501.00 - 1,527.30 |
| 52-Week Range | 1,335.00 - 1,702.05 |
| Beta | 0.10 |
| RSI | 36.86 |
| Earnings Date | Oct 30, 2025 |
About Cipla
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe... [Read more]
Financial Performance
In 2024, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.
Financial StatementsNews
Stock market live updates today: Indian share market updates, Sensex & Nifty on 25 Sept 2025
Welcome to Business Upturn’s live coverage of the Indian stock market on Thursday, 25 September 2025. The trading session is expected to remain stock-specific as several companies announced key develo...
Nifty 50 top losers today, September 22: Tech Mahindra, TCS, Infosys, Cipla, Wipro, HCL Technologies and more
Indian benchmark indices ended the session on a cautious note on September 22. The Sensex fell 466.26 points to 82,159.97, while the Nifty slipped 124.70 points to 25,202.35. Here’s a look at Nifty to...
Nifty top gainers today, September 18: Eternal, HDFC Life, Sun Pharma, Cipla, Infosys and more
Indian equity benchmarks closed higher on September 18. The BSE Sensex rose 320.25 points, or 0.39%, to end at 83,013.96, while the NSE Nifty 50 gained 93.35 points, or 0.37%, to finish at 25,423.60. ...
Nifty 50 top losers today, September 15: Cipla, Asian Paints, Mahindra & Mahindra, Shriram Finance, Dr. Reddy’s and more
Indian equity markets ended on a subdued note on September 15, with benchmark indices slipping in a rangebound session. The Sensex fell 118.96 points, or 0.15 percent, to 81,785.74, while the Nifty cl...
Nifty top losers this week (ending September 5): HCL Technologies, Wipro, Cipla, Infosys, HDFC Life and more
Indian equity benchmarks ended the week higher, with the Sensex up 1.3% and the Nifty 50 rising 1.1% after the GST Council’s decision to reduce levies on essential goods. Despite the weekly gains, mar...
Nifty 50 top losers today, September 5: ITC, Cipla, HCL Technologies, TCS, Tech Mahindra and more
Indian benchmark indices ended largely flat in a choppy trading session on September 5. While the Sensex slipped marginally by 7.25 points to close at 80,710.76, the Nifty managed a slight gain of 6.7...
Nifty 50 top gainers and losers today, August 21: Cipla, Dr. Reddy’s Laboratories, Bajaj Finserv among top performers
The Indian stock market continued its positive momentum for the sixth straight session on August 21, with benchmarks ending higher. The BSE Sensex climbed 142.87 points to close at 82,000.71, up 0.17%...
Cipla receives VAI classification from USFDA for Bengaluru facility
Cipla has announced that the United States Food and Drug Administration (USFDA) has classified its recent inspection at the company’s manufacturing facility in Bommasandra, Bengaluru, as Voluntary Act...
Nifty 50 top losers today, August 1: Sun Pharma, Dr. Reddy’s Laboratories, Adani Enterprises, Cipla and more
Indian equity markets ended Friday’s session (August 1) on a weak note, with both benchmark indices registering sharp declines. The BSE Sensex fell 585.67 points to settle at 80,599.91, while the NSE ...
Nifty top losers today, July 30: Tata Motors, Hero MotoCorp, Power Grid, Cipla, Bajaj Auto and more
Indian stock markets wrapped up Wednesday’s session (July 30) on a mildly positive note, with the benchmark Nifty 50 settling at 24,855.05, up by 0.14%. The Sensex also saw a modest uptick, rising 143...
Nifty top gainers today, July 28: Shriram Finance, Cipla, Hero MotoCorp, Asian Paints, Hindustan Unilever and more
Indian equity benchmarks ended in the red on July 28, with the Nifty slipping below the 24,700 mark. The Sensex fell 572.07 points, or 0.70%, to close at 80,891.02, while the Nifty declined 156.10 poi...
Top stocks to buy this week: What's the outlook for Nifty? Check stock recommendations
Stock market recommendations: SBI Securities' Sudeep Shah suggests Shyam Metalics and Energy Ltd and Cipla as top stock picks for the week starting July 28, 2025. Nifty faces downward pressure due to ...
Stocks to watch on brokerages, July 28: Mphasis, Cipla, Kotak Bank, Laurus Labs, IDFC First Bank, Bank of Baorda, SBI Cards, and more in focus
A full of brokerage actions is likely to impact several stocks on July 28, as global and domestic firms issued fresh views following earnings and business developments. Key names on the radar include ...
Jefferies maintains hold on Cipla, sets Rs 1,690 target as weak India and US growth offset by strong ROW and margin guidance
Jefferies has maintained a Hold rating on Cipla, with a target price of ₹1,690, indicating a potential upside of about 10.1% from the current market price of ₹1,535.00. While India business grew 6% ye...
Nomura maintains buy on Cipla, sees 18% upside on domestic recovery hopes and new US launches
Nomura has maintained a Buy rating on Cipla with a target price of ₹1,810, implying an upside of approximately 18% from the current market price of ₹1,535.00. The brokerage stated that Q1FY26 results ...
Goldman Sachs maintains sell on Cipla, cuts target to Rs 1,375 as gRevlimid boost fades despite strong Q1 margin beat
Goldman Sachs has reiterated a Sell rating on Cipla, with a target price of ₹1,375 — implying a downside of approximately 10.4% from the current market price of ₹1,535.00. The company’s Q1FY26 results...
Nifty top gainers this week (July 26): Eternal, ICICI Bank, Cipla, HDFC Life, Hindalco Industries and more
The Indian stock market wrapped up the week ending July 26, 2025, deep in negative territory, extending its losing streak to a fourth consecutive week — the longest such stretch this year and the firs...
Cipla Q1 results: Cipla Q1 profit rises 10% to Rs 1,298 crore; revenue grows to Rs 6,957 crore on India, Africa boost
Cipla reported a 10% increase in consolidated profit after tax, reaching ₹1,298 crore for Q1 FY26, driven by strong sales in India, Europe, and Africa. Total income from operations rose to ₹6,957 cror...
Nifty top gainers today, July 25: Cipla, SBI Life, Apollo Hospitals, Dr. Reddy’s Laboratories and more
Indian markets ended in the red on July 25, with the Sensex falling 721 points to 81,463.09 and the Nifty slipping 225 points to close at 24,837. Despite the broad sell-off, select Nifty 50 stocks man...
Cipla Q1 Results: Shares jump over 2% as net profit jumps 9.9% YoY
Shares of Cipla Limited climbed 2.05% to Rs 1,518.40 in Wednesday’s trade after the company reported steady Q1 FY26 earnings. The stock gained Rs 30.50 from the previous close of Rs 1,487.90 and touch...
Cipla Q1 results: Revenue up 3.9% YoY to Rs 6,957 crore, Net profit rises 9.9% YoY
Cipla Limited reported its financial results for the first quarter ended June 30, 2025, registering steady growth in both revenue and profitability. The company posted a revenue of Rs 6,957.47 crore i...
Stocks to watch on Q1 results today, July 25: Bajaj Finserv, Bank of Baroda, Cipla, SAIL, SBICard, Shriram Finance, and 40 others in focus
Indian equities are set for an action-packed session on Thursday, July 25, as several major and mid-sized companies will announce their financial results for the first quarter of FY26. Among the key n...
Nifty 50 top losers today, July 16: Shriram Finance, Eternal, Sun Pharma, Cipla, Tata Steel and more
Indian stock markets wrapped up July 16 on a quiet but positive note, with both Sensex and Nifty 50 posting modest gains. The Sensex inched up by 63.57 points to end at 82,634.48, while the Nifty 50 a...
Cipla eyes weight management foray: CEO
Cipla, a prominent drug manufacturer based in Mumbai, is set to enter the weight management market in India, according to MD and Global CEO Umang Vohra's FY25 annual report. The company is also focusi...
Morgan Stanley turns selective on Indian pharma, initiates call on Sun Pharma, Lupin, DRL, CIPLA shares
Morgan Stanley has initiated coverage on India’s four largest pharmaceutical companies by market capitalization — Sun Pharma, Lupin, Dr. Reddy’s Labs (DRL), and Cipla — with a broadly cautious outlook...